Pegasus Partners’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.44M | Hold |
21,179
| – | – | 0.14% | 46 |
|
|
2024
Q2 | $895K | Sell |
21,179
-887
| -4% | -$48.8K | 0.09% | 64 |
|
|
2024
Q1 | $1.52M | Hold |
22,066
| – | – | 0.16% | 57 |
|
|
2023
Q4 | $1.63M | Hold |
22,066
| – | – | 0.19% | 52 |
|
|
2023
Q3 | $1.51M | Hold |
22,066
| – | – | 0.21% | 52 |
|
|
2023
Q2 | $2.07M | Sell |
22,066
-268
| -1% | -$20.9K | 0.3% | 42 |
|
|
2023
Q1 | $1.51M | Buy |
22,334
+699
| +3% | +$44.9K | 0.24% | 47 |
|
|
2022
Q4 | $1.07M | Hold |
21,635
| – | – | 0.18% | 55 |
|
|
2022
Q3 | $703K | Buy |
21,635
+35
| +0.2% | +$1.44K | 0.14% | 68 |
|
|
2022
Q2 | $851K | Sell |
21,600
-9,400
| -30% | -$503K | 0.18% | 67 |
|
|
2022
Q1 | $2.17M | Sell |
31,000
-163
| -0.5% | -$11.9K | 0.38% | 37 |
|
|
2021
Q4 | $2.42M | Buy |
31,163
+1,548
| +5% | +$137K | 0.42% | 35 |
|
|
2021
Q3 | $2.83M | Buy |
29,615
+215
| +0.7% | +$22.7K | 0.51% | 26 |
|
|
2021
Q2 | $3.65M | Buy |
29,400
+13,380
| +84% | +$1.6M | 0.71% | 21 |
|
|
2021
Q1 | $2.11M | Buy |
16,020
+11,000
| +219% | +$1.51M | 0.46% | 38 |
|
|
2020
Q4 | $665K | Sell |
5,020
-419
| -8% | -$50.7K | 0.17% | 106 |
|
|
2020
Q3 | $555K | Buy |
5,439
+2,600
| +92% | +$225K | 0.17% | 103 |
|
|
2020
Q2 | $247K | Buy |
+2,839
| New | +$227K | 0.08% | 129 |
|
|
2019
Q3 | – | Sell |
-1,919
| Closed | -$227K | – | 186 |
|
|
2019
Q2 | $227K | Sell |
1,919
-500
| -21% | -$50.4K | 0.07% | 168 |
|
|
2019
Q1 | $210K | Buy |
+2,419
| New | +$206K | 0.06% | 132 |
|
|
2018
Q3 | – | Sell |
-7,194
| Closed | -$430K | – | 140 |
|
|
2018
Q2 | $430K | Sell |
7,194
-8,281
| -54% | -$446K | 0.1% | 121 |
|
|
2018
Q1 | $624K | Hold |
15,475
| – | – | 0.14% | 111 |
|
|
2017
Q4 | $813K | Sell |
15,475
-10,825
| -41% | -$578K | 0.17% | 124 |
|
|
2017
Q3 | $1.24M | Sell |
26,300
-2,400
| -8% | -$96.6K | 0.28% | 91 |
|
|
2017
Q2 | $1.01M | Sell |
28,700
-17,955
| -38% | -$554K | 0.27% | 99 |
|
|
2017
Q1 | $1.1M | Sell |
46,655
-2,000
| -4% | -$39.6K | 0.45% | 58 |
|
|
2016
Q4 | $650K | Sell |
48,655
-4,900
| -9% | -$79.1K | 0.29% | 87 |
|
|
2016
Q3 | $995K | Hold |
53,555
| – | – | 0.47% | 53 |
|
|
2016
Q2 | $656K | Hold |
53,555
| – | – | 0.34% | 79 |
|
|
2016
Q1 | $361K | Hold |
53,555
| – | – | 0.2% | 101 |
|
|
2015
Q4 | $494K | Buy |
53,555
+27,500
| +106% | +$256K | 0.25% | 67 |
|
|
2015
Q3 | $469K | Buy |
26,055
+10,500
| +68% | +$241K | 0.27% | 56 |
|
|
2015
Q2 | $463K | Buy |
+15,555
| New | +$391K | 0.2% | 65 |
|
Other funds holding EXAS
Pegasus Partners's EXAS Position: Q3 2024 in Review
Pegasus Partners held its Exact Sciences (EXAS) position steady in Q3 2024 at 21,179 shares worth $1.44M. The position accounts for 0.14% of the portfolio, ranked #46.
Pegasus Partners first reported a position in EXAS in Q2 2015 and has held it in 33 quarters since. The position peaked at $3.65M in Q2 2021. 598 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.
- Pegasus Partners held 21,179 shares of Exact Sciences worth $1.44M as of Q3 2024.
- Pegasus Partners left its Exact Sciences share count unchanged in Q3 2024.
- Exact Sciences made up 0.14% of Pegasus Partners's portfolio in Q3 2024, its #46 holding.
- Pegasus Partners first reported a position in Exact Sciences in Q2 2015 and has held it in 33 quarters since.
- Pegasus Partners's Exact Sciences position peaked at $3.65M in Q2 2021.
- 598 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.
Based on Pegasus Partners's 13F filing for Q3 2024, filed 1 Nov 2024.